Skip to content

An investigation on the effect of glucosamine intake on improving bowel movements

An investigation on the effect of glucosamine intake on improving bowel movements -Open Label Single Arm Trial- - Effect of glucosamine on improving bowel movements -Single Arm Trial-

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000056757
Enrollment
20
Registered
2025-02-10
Start date
2025-01-30
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Constipation tendency in adults

Interventions

Intake of glucosamine 1500mg per day for 14 days

Sponsors

SOUKEN Co., Ltd.
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1) Japanese men and women aged 20 to 59 at the time of consent 2) Subjects with a bowel movement frequency of 3 to 5 times per week

Exclusion criteria

Exclusion criteria: 1) Those taking medicines that may affect the test results (medicines with intestinal regulating effects, antibiotics, etc.) 2) Those who regularly consume health foods that may affect the test results (lactic acid bacteria, oligosaccharides, supplements that claim to regulate the intestines, etc.) or health foods that contain the same main ingredients as the test product 3) Pregnant or potentially pregnant women, and breastfeeding women 4) Those with alcoholism 5) Those who may have allergic reactions to the test product ingredients 6) Those participating in other clinical trials 7) Those with a history of severe liver damage, kidney damage, or heart disease 8) Those with a history of hepatitis or current illness 9) Those with severe anemia

Design outcomes

Primary

MeasureTime frame
Bowel movements (the previous observation period (2 weeks) and the 2 weeks-intake period after starting intake)

Countries

Japan

Contacts

Public ContactTomoya Shintani

TOYO INSTITUTE of FOOD TECHNOLOGY Research department

tomoya_shintani@shokuken.or.jp072-740-3300

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026